Market Overview

Morgan Stanley Sees Strong Growth Potential for Cerner

Related CERN
Top 4 NASDAQ Stocks In The Healthcare Information Services Industry With The Lowest PEG Ratio
Cerner to Offer OTTR Solutions - Analyst Blog

In a report published Wednesday, Morgan Stanley analyst Ricky R. Goldwasser reiterated an Equal-Weight rating on Cerner (NASDAQ: CERN).

In the report, Morgan Stanley noted, “4Q13 bookings of $1.11B exceeded guidance of $1-$1.1B, up 9% y/y and 19% seq. Ex-marquee Intermountain deal ($100-$135M), would imply range of -4% to -1% y/y and 5%-9% seq. However, 1Q14 bookings guidance of $860-$930M implies strong 7-16% y/y growth, while seq decline of -22% to -16% is above recent historical trends of -21% in 1Q13 and -27% in 1Q12.”

Cerner Corporation closed on Tuesday at $56.60.

Posted-In: Morgan Stanley Ricky R. GoldwasserAnalyst Color Reiteration Analyst Ratings


Most Popular

Related Articles (CERN)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free